Pharma container firm Envirotainer is expanding its presence in China with the addition of a station in Beijing.
The Beijing station will house Envirotainer's containers, the RKN e1 and RAP e2, and will enable the company to support the rapidly growing Chinese pharma export market.
Envirotainer's Beijing station is the 35th to carry the company's flagship RAP e2 container (pictured), which is a “cost efficient and high-performing solution compared with other active and passive alternatives”.
Eddy Cojulun, chief sales officer at Envirotainer, commented: “Looking ahead there are many uncertainties related to Covid-19 vaccine shipments. As an industry, we need to ensure that we have a solid temperature-controlled airfreight supply-chain to secure that the vaccines are delivered safely.
“Once a vaccine becomes available, we know it will require temperature-controlled airfreight and a global distribution in very large quantities. We expect that our investment in the Beijing station will further support a fast and secure delivery of Covid-19 vaccines to the people that need them, wherever they are in the world.”
Suat Toh, head of sales APAC at Envirotainer, added: “The Beijing area is a growing pharmaceutical hub for all types of temperature-sensitive cargo. We are currently supporting our Beijing based customers via our station in Shanghai. With the new station we want to create a significantly better customer experience for our Beijing area customers by reducing the need for trucking units between regions.
“At the same time, we also extend the overall capacity in the greater APAC region to meet the rising demand for a secure and cost-efficient proven solution, especially in light of the ongoing pandemic.”